iTeos Therapeutics to Connect with Investors at Upcoming Conferences
iTeos Therapeutics, Inc. (NASDAQ: ITOS), a clinical-stage biopharmaceutical company recognized for its innovative work in immuno-oncology, has announced its involvement in two significant investor conferences scheduled for September.
Conference Participation Details
The management team of iTeos will be participating in the following events:
2024 Wells Fargo Healthcare Conference
Format: Fireside chat and individual investor meetings
Date: Early September
Time: 4:30 PM ET
Cantor Fitzgerald Global Healthcare Conference
Format: Fireside chat and one-on-one meetings
Date: Mid-September
Time: 10:20 AM ET
Investment Opportunities and Webcast Details
Attendees will have the opportunity to engage with iTeos management through one-on-one meetings, where they can ask questions and discuss the company's strategic initiatives. A live webcast of the presentations will be available in the Investors section of the iTeos website. After the live event, archived presentations will be accessible for about 30 days, ensuring that all interested parties can stay updated.
About iTeos Therapeutics, Inc.
iTeos Therapeutics is leading the way in biopharmaceutical innovation, focusing on the development of advanced immuno-oncology therapeutics. By utilizing a deep understanding of tumor immunology and its associated pathways, the company creates novel product candidates designed to boost the immune response against cancer.
The company has a strong clinical pipeline that features three clinical-stage programs targeting innovative immunosuppressive pathways. These programs are meticulously crafted to enhance clinical outcomes through mechanisms such as the TIGIT/CD226 axis and the adenosine pathway. iTeos Therapeutics is dedicated to advancing these initiatives, which have the potential to make a significant difference in patient care.
Contact Information for Investors and Media
For further inquiries, interested parties can directly contact the company’s investor and media relations teams:
Investor Contact:
Carl Mauch
iTeos Therapeutics, Inc.
Email: carl.mauch@iteostherapeutics.com
Media Contact:
Email: media@iteostherapeutics.com
Frequently Asked Questions
What are the upcoming conferences iTeos will participate in?
iTeos Therapeutics will be attending the Wells Fargo Healthcare Conference and the Cantor Fitzgerald Global Healthcare Conference.
What is the focus of iTeos Therapeutics?
The company specializes in developing immuno-oncology therapeutics that enhance the immune response against cancer.
How can investors access the conference presentations?
Investors can view the live webcast of the presentations in the Investors section of the iTeos website, with archived recordings available for 30 days afterward.
What is the significance of the conferences for iTeos?
The conferences offer a platform for iTeos management to connect directly with investors, discuss the company's developments, and explore potential collaborations or funding opportunities.
Where is iTeos Therapeutics headquartered?
iTeos Therapeutics is based in Watertown, Massachusetts, with a research facility located in Gosselies, Belgium.